SGHT Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
24.9M
+6.6%
23.4M
+18.7%
19.7M
-3.4%
20.4M
+2.4%
19.9M
Cost of Revenue
3.5M
+73.9%
2.0M
-26.0%
2.7M
+4.7%
2.6M
-4.1%
2.7M
Gross Profit
21.4M
+0.2%
21.4M
+25.9%
17.0M
-4.6%
17.8M
+3.4%
17.2M
Operating Expenses
27.5M
+9.0%
25.3M
-14.0%
29.4M
+37.0%
21.5M
-14.5%
25.1M
R&D
2.7M
+7.7%
2.5M
-1.3%
2.5M
+4.5%
2.4M
-27.3%
3.4M
SG&A
24.8M
+9.2%
22.8M
-15.3%
26.8M
+41.1%
19.0M
-12.6%
21.8M
Operating Income
-6128000
-57.6%
-3888000
+68.7%
-12413000
-238.3%
-3669000
+53.6%
-7905000
EBITDA
-6018000
-58.6%
-3794000
+69.2%
-12310000
-245.7%
-3561000
+54.3%
-7800000
Net Income
-6810000
-53.2%
-4446000
+65.7%
-12980000
-211.9%
-4162000
+49.1%
-8169000
EPS (Basic)
$-0.12
-50.0%
$-0.08
+66.7%
$-0.24
-200.0%
$-0.08
+50.0%
$-0.16
EPS (Diluted)
$-0.12
-50.0%
$-0.08
+66.7%
$-0.24
-200.0%
$-0.08
+50.0%
$-0.16
Shares (Diluted)
55.1M
+1.1%
54.5M
+1.0%
53.9M
+1.6%
53.1M
+1.4%
52.4M
Sight Sciences (SGHT) — Financials